...
首页> 外文期刊>Japanese Journal of Pharmacology >The Effect of Prophylactic Anti-Asthma Drugs on PAF-Induced Airway Hyperreactivity
【24h】

The Effect of Prophylactic Anti-Asthma Drugs on PAF-Induced Airway Hyperreactivity

机译:预防性抗哮喘药对PAF诱导的气道高反应性的影响

获取原文

摘要

References(46) Cited-By(6) Intravenous injection of platelet activating factor (PAF) in anesthetized guinea pigs induces non-selective airway hyperreactivity. This response to PAF was reduced in a dose-dependent manner by systemic administration of established prophylactic anti-asthma drugs (ketotifen, cromoglycate, aminophylline and glucocorticosteroids) and by competitive antagonists of PAF. These inhibitory effects could not be accounted for by antagonism of histamine (H1), serotonin or peptidoleukotrienes receptors; parasympatholytic activity; cyclo-oxygenase or lipoxygenase inhibition; mast cell stabilization; or bronchodilatation. Infusion or injection of PAF to induce airway hyperreactivity in the guinea pig may provide a prospective test for prophylactic anti-asthma drugs.
机译:参考文献(46)被引用的文献(6)在麻醉的豚鼠中静脉注射血小板活化因子(PAF)会引起非选择性气道高反应性。通过全身给药已建立的预防性哮喘药(酮替芬,色甘酸,氨茶碱和糖皮质激素)和PAF的竞争性拮抗剂,可以降低剂量对PAF的反应。组胺(H1),5-羟色胺或肽白三烯受体的拮抗作用不能解释这些抑制作用。副交感神经活性抑制环加氧酶或脂氧合酶;肥大细胞稳定;或支气管扩张。注入或注射PAF诱导豚鼠气道反应过度可能为预防性抗哮喘药物提供前瞻性测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号